|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-2-9
|
|
pubmed:abstractText |
Poor sleep is common in MS and it contributes to fatigue. The beta interferons produce systemic effects which may not adapt and may induce fatigue.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1477-0970
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
238-47
|
|
pubmed:meshHeading |
pubmed-meshheading:20028705-Actigraphy,
pubmed-meshheading:20028705-Adult,
pubmed-meshheading:20028705-Disability Evaluation,
pubmed-meshheading:20028705-Drug Administration Schedule,
pubmed-meshheading:20028705-Fatigue,
pubmed-meshheading:20028705-Humans,
pubmed-meshheading:20028705-Immunologic Factors,
pubmed-meshheading:20028705-Interferon-beta,
pubmed-meshheading:20028705-Middle Aged,
pubmed-meshheading:20028705-Motor Activity,
pubmed-meshheading:20028705-Multiple Sclerosis, Relapsing-Remitting,
pubmed-meshheading:20028705-Peptides,
pubmed-meshheading:20028705-Predictive Value of Tests,
pubmed-meshheading:20028705-Questionnaires,
pubmed-meshheading:20028705-Severity of Illness Index,
pubmed-meshheading:20028705-Sleep,
pubmed-meshheading:20028705-Sleep Disorders,
pubmed-meshheading:20028705-Time Factors,
pubmed-meshheading:20028705-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study.
|
|
pubmed:affiliation |
Multiple Sclerosis Rehabilitation Unit, Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
